Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 11 New Drugs to Be Officially Approved in April
April 7, 2008
- Treatment Architecture Japan 2007 Published by Synix
March 31, 2008
- REGULATORY NEWS IN BRIEF
March 31, 2008
- GENERICS NEWS IN BRIEF
March 31, 2008
- OPINION／The Scuttlebutt on Pharma Takeovers
March 31, 2008
- 78 Generics of Amlodipine from 38 Companies Approved
March 31, 2008
- PET Facility Goes Bankrupt
March 31, 2008
- 16 APIs See Approval of 1st Generics
March 31, 2008
- 2 Former Company Employees Assigned to PMDA's Review Division within 2 Years of Employment
March 31, 2008
- BUSINESS NEWS IN BRIEF
March 31, 2008
- Reduction in Yakkasa Essential for Drug Pricing System Reform Proposed by Industry: FPMAJ President
March 31, 2008
- 2nd Dialogue Held by Korosho and FJPWA
March 31, 2008
- NBI and Pfizer to Initiate e-Detailing for Spiriva
March 31, 2008
- GSK Promotes Adoair Anticipating Lifting of 2-Week Limitation on Prescriptions
March 31, 2008
- Kissei Has Candidate for Next Global Strategic Product at PI: President Kanzawa
March 31, 2008
- MEDICAL DEVICE NEWS IN BRIEF
March 31, 2008
- Astellas to Enhance Global Management System
March 31, 2008
- R&D NEWS IN BRIEF
March 31, 2008
- Takeda Announces Restructuring of US Operations
March 31, 2008
- JAPhMed Seminar Covers Wide Range of Topics
March 31, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…